Serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 in girls with premature thelarche

Journal of Pediatric Endocrinology and Metabolism

Volumn 16, Issue 6, 2003, Pages 827-833

  Sales, Débora S ^a   Moreira, Ayrton C ^a   Camacho Hübner, Cecilia ^b   Ricco, Rubens G ^a   Daneluzzi, Júlio C ^a   Campos, Antônio D ^a   Martinelli Jr , Carlos E ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

IGF I; IGFBP 3; Precocious puberty; Premature thelarche; Puberty

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

AGING; ARTICLE; BREAST DEVELOPMENT; CHILD; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEVELOPMENTAL STAGE; DISEASE CLASSIFICATION; FEMALE; HORMONE BLOOD LEVEL; HUMAN; IMMUNORADIOMETRIC ASSAY; LABORATORY TEST; PRECOCIOUS PUBERTY; PROTEIN BLOOD LEVEL; PUBERTY; STATISTICAL ANALYSIS;

EID: 0141960446     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2003.16.6.827     Document Type: Article

References (21)

1. Mauras N, Rogol AD, Haymond MW, Veldhuis JD. Sex steroids, growth hormone, insulin-like growth factor-1: neuroendocrine and metabolic regulation in puberty. Horm Res 1996; 45: 74-80.
2. Juul A, Bang P, Hertel NT, Main K, Dalgaard P, Jorgensen K, Müller J, Hall K, Skakkebaek NE. Serum insulin-like growth factor-I in 1030 healthy children, adolescents and adults: relation to age, sex, stage of puberty, testicular size and body mass index. J Clin Endocrinol Metab 1994; 78: 744-752.
3. Juul A, Dalgaard P, Blum WF, Bang P, Hall K, Michaelsen KF, Müller J, Skakkebaek NE. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children and adolescents: the relation to IGF-I, IGF-II, IGFBP-I, IGFBP-2, age, sex, body mass index and pubertal maturation. J Clin Endocrinol Metab 1995; 80: 2534-2542.
4. Bridges NA, Brook CDG. Disorders of puberty. In: Brook CDG, ed. Clinical Paediatric Endocrinology. London: Blackwell Science Ltd., 1995; 253-273.
5. Juul A, Scheike T, Nielsen CT, Krabbe S, Müller J, Skakkebaek NE. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate). J Clin Endocrinol Metab 1995; 80: 3059-3067.
6. Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in girls. Arch Dis Child 1969; 44: 291-303.
7. Brito VN, Batista MC, Borges MF, Latronico AC, Kohec MBF, Thirone ACP, Jorge BH, Arnhold IJP, Mendonça BB. Diagnostic value of fluorometric assays in the evaluation of precocious puberty. J Clin Endocrinol Metab 1999; 84: 3539-3544.
8. Greulich WW, Pyle ST. Radiographic Atlas of Skeletal Development of Hand and Wrist. Stanford, CA: Stanford University Press, 1959.
9. Moreira AC, Castro M, Maciel LMZ, Hiltner A. Luteinizing hormone response to clomiphene citrate in central precocious puberty. Clin Endocrinol 1992; 45: 73-77.
10. Norjavara E, Ankarberg C, Albertsson-Wikland K. Diurnal rhythm of 17β-estradiol secretion throughout pubertal development in healthy girls: evaluation by a sensitive radioimmunoassay. J Clin Endocrinol Metab 1996; 81: 4095-4102.
11. Janssen YJH, Helmerhorst F, Frölich M, Roelfsema F. A switch from oral (2 mg/day) to transdermal (50 μg/day) 17β-estradiol therapy increases serurn insulin-like growth factor-I levels in recombinant human growth hormone (GH)-substituted women with GH deficiency. J Clin Endocrinol Metab 2000; 85: 464-467.
12. Kam GYW, Leung K, Baxter RC, Ho KKY. Estrogens exert route- and dose-dependent effects on insulin-like growth factor (IGF)-binding-protein-3 and the acidlabile subunit of the IGF ternary complex. J Clin Endocrinol Metab 2000; 85: 1918-1922.
13. Kanety H, Karasik A, Pariente C, Kauschansky A. Insulin-like growth factor-I and IGF binding-protein-3 remain high after GnRH analogue therapy in girls with central precocious puberty. Clin Endocrinol 1996; 45: 7-12.
14. Verrotti A, Ferrari M, Sabatino G, Morgese G, Chiarelli F. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels in children with precocious puberty treated with gonadotropin-releasing hormone analog without or in combination with cyproterone acetate. Gynecol Endocrinol 1997; 11: 243-250.
15. Erfurth EMT, Hagmar LE, Sääf M, Hall K. Serum levels of insulin-like growth factor I and insulin-like growth factor-binding protein 1 correlate with serum free testosterone and sex hormone binding globulin levels in healthy young and middle-aged men. Clin Endocrinol 1996; 44: 659-664.
16. Harris DA, Van Vliet G, Egli CA, Grumbach MM, Kaplan SL, Styne DM, Vainsel M. Somatomedin-C in normal puberty and in true precocious puberty before and after treatment with a potent luteinizing hormone-releasing hormone agonist. J Clin Endocrinol Metab 1985; 61: 152-159.
17. Juul A, Flyvbjerg A, Frystyk J, Müller J, Skakkebaek NE. Serum concentrations of free and total insulin-like growth factor-I, IGF-binding proteins-1 and -3 and IGFBP-3 protease activity in boys with normal or precocious puberty. Clin Endocrinol 1996; 44: 515-523.
18. Hofbauer LC, Khosla S. Androgen effects on bone metabolism: recent progress and controversies. Eur J Endocrinol 1999; 140: 271-286.
19. Gori F, Hofbauer LC, Conover CA, Khosla S. Effects of androgens on the insulin like growth factor system in androgen-responsive human osteoblastic cell line. Endocrinology 1999; 140: 5579-5586.
20. Yoshizawa A, Clemmons DR. Testosterone and insulin-like growth factor (IGF) I interact in controlling IGF-binding protein production in androgen-responsive foreskin fibroblasts. J Clin Endocrinol Metab 2000; 85: 1627-1633.
21. Fisker S, Norrelund H, Juul A, Skakkebaek NE, Christiansen JS, Jorgensen JO. The growth hormone (GH)-insulin-like growth factor axis during testosterone replacement therapy in GH-treated hypopituitary males. Growth Horm IGF Res 2001; 11: 104-109.